Author

Yoshifumi Ohkura

Observed name: Yoshifumi OHKURA

Institution: Hiroshima University

Observed institution: Hiroshima University

OpenAlex ID: A5111867164

Effect of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on the induction of low-density lipoprotein receptor in HepG2 cells

1993 · Kozo Hayashi, Jun-ichi Kurokawa, et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 26

Reduction of Plasma Cholesterol Levels and Induction of Hepatic LDL Receptor by Cerivastatin Sodium (CAS 143201-11-0, BAY w 6228), a New Inhibitor of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase, in Dogs

1997 · Yuji Yasunobu, Kozo Hayashi, et al. · Cardiovascular Drugs and Therapy · 12

Effect of pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on hepatic cholesterol 7α-hydroxylase, acyl-coenzyme A: cholesterol acyltransferase, and bile lipid secretion in the hamster with intact enterohepatic circulation

1994 · Kozo Hayashi, Mitsuhide Noshiro, et al. · Atherosclerosis · 7

Partial Cloning of cDNA for Hamster Liver Cholesterol 7.ALPHA.-Hydroxylase.

1993 · Kozo HAYASHI, Hitoshi KURUSHIMA, et al. · Internal Medicine · 7

2.P.94 Reduction of plasma cholesterol levels and inhibition of smooth muscle cell (SMC) proliferation by cerivastatin sodium, a new HMG-CoA reductase inhibitor

1997 · Yuji Yasunobu, Kozo Hayashi, et al. · Atherosclerosis · 1

Works count: 5

Citation count: 53

H-index: 4

I10-index: 2